Market Overview:
The global pharmaceutical grade amino acid market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for pharmaceutical grade amino acids from various applications such as hormones, antibacterial agents, anti-cancer drugs, nutrition and others. Additionally, the growing awareness about the benefits of using pharmaceutical grade amino acids is also contributing to the growth of this market. North America dominates the global pharmaceutical grade amino acid market and is expected to continue its dominance during the forecast period.
Product Definition:
A pharmaceutical grade amino acid is an amino acid that has been purified and meets the standards set by the United States Pharmacopoeia (USP). This means that it is free of contaminants and has a consistent chemical composition. Pharmaceutical grade amino acids are used in dietary supplements, medical foods, and other therapeutic products.
Glutamine:
Glutamine is a non-essential amino acid and plays an important role in the growth of cells. It is also known as the building block for protein, which means it's a key ingredient in any body tissue or organ. The human body cannot produce glutamine synthetically; therefore, it has to be supplied through diet or supplementation.
Threonine:
Threonine is a non-essential amino acid and plays an important role in the human body. It is used as a raw material for manufacturing pharmaceutical grade amino acids, which are further used to produce proteins that aid in the healing process of diseases such as arthritis, asthma, etc. Threonine helps build healthy hair and nails; it also aids in reducing cholesterol levels and blood pressure.
Application Insights:
Nutraceutical grade amino acids are used in the formulation of nutritional supplements. These products are available in multiple forms such as tablets, capsules and powder which can be consumed directly or mixed with foodstuffs. The increasing demand for these nutritional supplements to maintain muscle strength and stamina during training is anticipated to drive this segment over the forecast period.
The other application segment comprises of pharmaceutical drugs that contain amino acid as a primary ingredient for treating diseases or symptoms associated with them. This includes diabetes, cardiovascular disease, cancer treatment and obesity among others. The growing prevalence of these disorders coupled with rising healthcare costs is expected to drive their usage over the forecast period thereby fueling the market growth further.
Amino acid manufacturers have started manufacturing generic drugs using pharmaceutical grade aminos which can be sold at lower prices due to economies of scale thus providing wider opportunities for this product in various applications across all regions including North America, Europe, Asia Pacific.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is anticipated to maintain its position throughout the forecast period. This can be attributed to increasing R&D activities in this region, rising healthcare expenditure, and growing patient awareness levels regarding advanced therapeutics. The presence of key pharmaceutical companies such as Gilead Sciences, Inc.; Cipla Inc.; Dr Reddy's Laboratories; Sun Pharmaceutical Industries Ltd; WOCKHARDTECH CO., LTD.; Sanofi India; Novo Nordisk A/S; AstraZeneca Ldt are contributing towards growth of this region.
North America held a significant share owing to high prevalence of chronic diseases such as cancer & diabetes which require long term treatment solutions. Moreover, availability of effective regulatory pathways for approval process is also expected to drive product demand over the forecast period.
Growth Factors:
- Increasing demand for pharmaceutical grade amino acids from the nutraceutical and cosmeceutical industries as they are used in the production of a wide range of products such as dietary supplements, functional foods, personal care products, and animal feed.
- Growing research on the therapeutic potential of amino acids is expected to fuel their demand in the near future.
- Rising awareness about the benefits of using pharmaceutical grade amino acids is projected to boost their sales over the next few years.
- The increasing use of these compounds in drug discovery and development programs is likely to create new growth opportunities for this market in coming years. 5) Technological advancements that have led to improved production processes are anticipated to propel market growth during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Amino Acid Market Research Report
By Type
Glutamine, Threonine, Tryptophan, Others
By Application
Hormone, Antibacterial Agents, Anti-cancer Drugs, Nutrition, Others
By Companies
Ajinomoto Group, Evonik, Kyowa Hakko Kirin Co., Ltd., Vedan, Mitsui Chemicals, Star Lake Bioscience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Amino Acid Market Report Segments:
The global Pharmaceutical Grade Amino Acid market is segmented on the basis of:
Types
Glutamine, Threonine, Tryptophan, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hormone, Antibacterial Agents, Anti-cancer Drugs, Nutrition, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ajinomoto Group
- Evonik
- Kyowa Hakko Kirin Co., Ltd.
- Vedan
- Mitsui Chemicals
- Star Lake Bioscience
Highlights of The Pharmaceutical Grade Amino Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glutamine
- Threonine
- Tryptophan
- Others
- By Application:
- Hormone
- Antibacterial Agents
- Anti-cancer Drugs
- Nutrition
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Amino Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical grade amino acids are those that have been specifically manufactured to meet the specific needs of a drug or other medical product. They are typically more pure and consistent than those found in food, which can make them easier to use in pharmaceutical products.
Some of the major players in the pharmaceutical grade amino acid market are Ajinomoto Group, Evonik, Kyowa Hakko Kirin Co., Ltd., Vedan, Mitsui Chemicals, Star Lake Bioscience.
The pharmaceutical grade amino acid market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Grade Amino Acid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Grade Amino Acid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Grade Amino Acid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Grade Amino Acid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Grade Amino Acid Market Size & Forecast, 2020-2028
4.5.1 Pharmaceutical Grade Amino Acid Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Grade Amino Acid Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Glutamine
5.2.2 Threonine
5.2.3 Tryptophan
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hormone
6.2.2 Antibacterial Agents
6.2.3 Anti-cancer Drugs
6.2.4 Nutrition
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Grade Amino Acid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Grade Amino Acid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Glutamine
9.6.2 Threonine
9.6.3 Tryptophan
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hormone
9.10.2 Antibacterial Agents
9.10.3 Anti-cancer Drugs
9.10.4 Nutrition
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Glutamine
10.6.2 Threonine
10.6.3 Tryptophan
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hormone
10.10.2 Antibacterial Agents
10.10.3 Anti-cancer Drugs
10.10.4 Nutrition
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Glutamine
11.6.2 Threonine
11.6.3 Tryptophan
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hormone
11.10.2 Antibacterial Agents
11.10.3 Anti-cancer Drugs
11.10.4 Nutrition
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Glutamine
12.6.2 Threonine
12.6.3 Tryptophan
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hormone
12.10.2 Antibacterial Agents
12.10.3 Anti-cancer Drugs
12.10.4 Nutrition
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Glutamine
13.6.2 Threonine
13.6.3 Tryptophan
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hormone
13.10.2 Antibacterial Agents
13.10.3 Anti-cancer Drugs
13.10.4 Nutrition
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Grade Amino Acid Market: Competitive Dashboard
14.2 Global Pharmaceutical Grade Amino Acid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ajinomoto Group
14.3.2 Evonik
14.3.3 Kyowa Hakko Kirin Co., Ltd.
14.3.4 Vedan
14.3.5 Mitsui Chemicals
14.3.6 Star Lake Bioscience
